Carrie Brownstein - Net Worth and Insider Trading
Carrie Brownstein Net Worth
The estimated net worth of Carrie Brownstein is at least $323,396 dollars as of 2024-12-28. Carrie Brownstein is the Chief Medical Officer of Zentalis Pharmaceuticals Inc and owns about 105,685 shares of Zentalis Pharmaceuticals Inc (ZNTL) stock worth over $323,396. Details can be seen in Carrie Brownstein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carrie Brownstein has not made any transactions after 2023-10-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Carrie Brownstein
Carrie Brownstein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carrie Brownstein owns 2 companies in total, including Shattuck Labs Inc (STTK) , and Zentalis Pharmaceuticals Inc (ZNTL) .
Click here to see the complete history of Carrie Brownstein’s form 4 insider trades.
Insider Ownership Summary of Carrie Brownstein
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| STTK | Shattuck Labs Inc | 2021-10-22 | director |
| ZNTL | Zentalis Pharmaceuticals Inc | 2023-10-04 | Chief Medical Officer |
Carrie Brownstein Latest Holdings Summary
Carrie Brownstein currently owns a total of 1 stock. Carrie Brownstein owns 105,685 shares of Zentalis Pharmaceuticals Inc (ZNTL) as of October 4, 2023, with a value of $323,396.
Latest Holdings of Carrie Brownstein
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals Inc | 2023-10-04 | 105,685 | 3.06 | 323,396 |
Holding Weightings of Carrie Brownstein
Carrie Brownstein Form 4 Trading Tracker
According to the SEC Form 4 filings, Carrie Brownstein has made a total of 1 transactions in Zentalis Pharmaceuticals Inc (ZNTL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Zentalis Pharmaceuticals Inc is the sale of 10,628 shares on October 4, 2023, which brought Carrie Brownstein around $207,246.
Insider Trading History of Carrie Brownstein
- 1
Carrie Brownstein Trading Performance
Carrie Brownstein Ownership Network
Carrie Brownstein Owned Company Details
What does Shattuck Labs Inc do?
Who are the key executives at Shattuck Labs Inc?
Carrie Brownstein is the director of Shattuck Labs Inc. Other key executives at Shattuck Labs Inc include director & 10 percent owner Redmile Group, Llc , director & Chief Executive Officer Taylor Schreiber , and See Remarks Stephen Stout .
Shattuck Labs Inc (STTK) Insider Trades Summary
Over the past 18 months, Carrie Brownstein made no insider transaction in Shattuck Labs Inc (STTK). Other recent insider transactions involving Shattuck Labs Inc (STTK) include a net purchase of 50,900 shares made by Taylor Schreiber , a net sale of 0 shares made by Redmile Group, Llc , and a net sale of 25,000 shares made by Andrew R Neill .
In summary, during the past 3 months, insiders sold 133,371 shares of Shattuck Labs Inc (STTK) in total and bought 169,871 shares, with a net purchase of 36,500 shares. During the past 18 months, 174,375 shares of Shattuck Labs Inc (STTK) were sold and 192,687 shares were bought by its insiders, resulting in a net purchase of 18,312 shares.
Shattuck Labs Inc (STTK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Shattuck Labs Inc Insider Transactions
Carrie Brownstein Mailing Address
Above is the net worth, insider trading, and ownership report for Carrie Brownstein. You might contact Carrie Brownstein via mailing address: 500 W. 5th St., Suite 1200, Austin Tx 78701.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
